The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,913.00
Bid: 1,916.00
Ask: 1,918.00
Change: 59.00 (3.18%)
Spread: 2.00 (0.104%)
Open: 1,861.00
High: 1,920.00
Low: 1,861.00
Prev. Close: 1,854.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MARKET COMMENT: Shares Gain And Pound Falls On Tame UK Inflation

Tue, 19th Aug 2014 16:19

LONDON (Alliance News) - UK markets made strong gains for the second consecutive day, as investors took heart that geopolitical tensions seemed to be contained for the time being.

However, the pound dropped to its lowest level against the dollar for four months following the release of a lower-than-expected UK inflation reading.

The FTSE 100 ended the day up 0.6% at 6,779.31, and the FTSE 250 added 0.6% to 15,895.26, while the AIM All-Share gained 0.5% to 763.29.

In Europe markets performed even better, with the CAC 40 in Paris ending up 0.6%. while the German DAX finished 1.0% higher.

At the close of European markets, Wall Street also was trading higher. The DJIA was up 0.4%, the S&P 500 up 0.4% and the NASDAQ Composite up 0.2%.

UK consumer prices rose by 1.6% year-on-year in July, according to the latest data from the Office for National Statistics. That's down from the 1.9% rise in prices in June, and lower than the 1.8% CPI that had been predicted by economists. On a monthly basis, prices fell by 0.3%, reversing the 0.2% rise in June and falling faster that the 0.2% fall that had been expected.

The Bank of England is mandated to target CPI of 2.0%. The latest data represents a slip away from that goal and the seventh consecutive month of below-target inflation. The data will support the recent shift in market sentiment toward believing that UK interest rates are unlikely to rise until next year.

"Lower levels of inflation take the heat off the Bank of England to hike rates. This latest report won’t have been factored into the decision-making at the latest BOE meeting, but with core inflation below 2% anyway it seems entirely possible no members of the Monetary Policy Committee dissented the decision to keep interest rates unchanged," says Jasper Lawler, analyst at CMC Markets.

Wednesday's economic calendar is dominated by central banks, as minutes from the most recent Bank of England and Federal Reserve meetings will be released at 0930 BST and 1900 BST, respectively.

The pound was hit by the UK inflation news and was trading at USD1.6621 at the close of play in London.

In individual stock news, BHP Billiton was by some distance the biggest faller in the FTSE 100 after it confirmed that it will demerge its aluminium, coal, manganese, nickel and silver assets into a new company, pledging to cut costs and improve the productivity of its remaining businesses in an attempt to boost shareholder returns. The new Perth-based entity will be listed in Sydney and Johannesburg, rather than London.

The stock was further pushed down, according to Liberum, by BHP's failure to announce a "much anticipated" USD3 billion to USD5 billion share buyback. BHP ended the day down 4.5%.

Imperial Tobacco Group closed up 2.1% after it reported a slight fall in sales volume and revenue for the first nine months of its financial year, but left unchanged its full-year guidance for "modest" growth in earnings per share and a dividend increase of at least 10%.

Imperial Tobacco said its stock optimisation programme - by which it is reducing stock levels to improve supply and cost efficiencies - reduced trade inventories in a number of markets, especially Iraq and Russia, which has hit volume, revenue and profit. However, the company still expects "modest growth" in earnings per share at constant currency rates for the full financial year, accompanied by at least a 10% increase in dividend. It also said its cost-optimisation programme remains on track to deliver incremental savings of GBP60 million for the full year.

In the corporate calendar Wednesday, interim results will be reported from Glencore, Hikma Pharmaceuticals, Harvey Nash and UK Commercial Property Trust.

By Neil Thakrar; neilthakrar@alliancenews.com

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
1 Mar 2023 09:52

LONDON BROKER RATINGS: Canaccord says sell Future; Investec likes RWS

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
27 Feb 2023 09:38

Berenberg raises target price on Hikma Pharmaceuticals

(Sharecast News) - Analysts at Berenberg raised their target price on drugmaker Hikma Pharmaceuticals from 1,440.0p to 1,740.0p on Monday on the back of the group's recent trading update.

Read more
27 Feb 2023 09:26

LONDON BROKER RATINGS: Citi cuts Quilter to 'sell'; Goldman likes GSK

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
24 Feb 2023 09:37

LONDON BROKER RATINGS: SocGen cuts Burberry; BofA cuts WH Smith

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
23 Feb 2023 09:54

Hikma Pharmaceuticals profit halves in 2022 on Generics impairment

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reported a dip in annual revenue for 2022, as profit tumbled due to high inflation and adjustments regarding expectations for its Generics business.

Read more
23 Feb 2023 09:02

LONDON MARKET OPEN: Mixed open in London; Rolls-Royce up, Mondi down

(Alliance News) - Stock prices in London opened mixed on Thursday, with large-cap indices underperforming amid mixed corporate earnings.

Read more
23 Feb 2023 07:59

Competition in generics sees Hikma Pharmaceuticals's profits decline by a tenth

(Sharecast News) - Hikma Pharmaceuticals posted lower full-year profits as stiff competition in generics saw its top line growth flatten out.

Read more
23 Feb 2023 07:56

LONDON BRIEFING: WPP profit jumps in 2022; guides for further growth

(Alliance News) - Stocks in London were called to open slightly higher on Thursday, as investors were unfazed by a fairly uneventful set of policy meeting minutes from the US central bank.

Read more
22 Feb 2023 21:50

Hikma accuses Amarin of suppressing generic versions of heart pill

Hikma claims Amarin used exclusive agreements with suppliers to frustrate generic rivals

*

Read more
16 Feb 2023 15:49

UK earnings, trading statements calendar - next 7 days

Friday 17 February 
Allianz Technology Trust PLCFull Year Results
Kingspan Group PLCFull Year Results
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
Monday 20 February 
Bank of Cyprus Holdings PLCFull Year Results
Georgia Capital PLCFull Year Results
Goldplat PLCFull Year Results (TBC)
LungLife AI IncFull Year Results
Tristel PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 21 February 
Antofagasta PLCFull Year Results
BHP Group LtdHalf Year Results
Blancco Technology Group PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
HSBC Holdings PLCFull Year Results
InterContinental Hotels Group PLCFull Year Results
Safestore Holdings PLCTrading Statement
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Trifast PLCTrading Statement
Wednesday 22 February 
Avingtrans PLCHalf Year Results
City of London Investment Group PLCHalf Year Results
Conduit Holdings LtdFull Year Results
Liberty Global PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Primary Health Properties PLCFull Year Results
Renewables Infrastructure Group LtdFull Year Results
Rio Tinto PLCFull Year Results
Synectics PLCFull Year Results
TBC Bank Group PLCFull Year Results
Transense Technologies PLCHalf Year Results
Thursday 23 February 
Anglo American PLCFull Year Results
Arbuthnot Banking Group PLCTrading Statement
BAE Systems PLCFull Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Drax Group PLCFull Year Results
Driver Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Made Tech Group PLCHalf Year Results
Mondi PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
Versarien PLCFull Year Results
WPP PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
25 Jan 2023 09:33

LONDON BROKER RATINGS: Goldman likes UK banks; HSBC cuts Dr Martens

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
18 Jan 2023 15:07

Director dealings: Hikma Pharmaceuticals director snaps up shares

(Sharecast News) - Hikma Pharmaceuticals revealed on Wednesday that non-executive director Deneen Vojta had acquired 1,000 ordinary shares in the FTSE 250-listed drugmaker.

Read more
12 Jan 2023 17:55

Arecor transfers AT307 drug to Hikma for development, regains AT282

(Alliance News) - Arecor Therapeutics PLC on Thursday said it transferred development activities for the ready-to-use injectable medicine AT307 to Hikma Pharmaceuticals PLC, and regained rights on AT282 after a product portfolio review.

Read more
3 Jan 2023 17:31

FTSE 100 ends first trading day of 2023 on upbeat note

FTSE 100 up 1.4%, FTSE 250 adds 1.5%

*

Read more
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.